Seretide Inhaler

Medicinal product

(Invented) name

Seretide Inhaler

Active substance (s)

Salmeterolis/Flutikazono propionatas

Strength

25 µg/50 µg/dozėje

Pharmaceutical form

suslėgtoji įkvepiamoji suspensija

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R03AK06, Salmeterol and fluticasone

Marketing authorisation holder

GlaxoSmithKline Trading Services Limited, Airija

Date of authorisation

2001-05-16

Date of renewal

2009-05-13

Documents

1576 Pakuotės lapelis 2022 03 04.docx

1576 Seretide Inhaler susl ikvep susp RPP 2022 03 04.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Dozėje yra	1 dozėje
Salmeterolis	25 µg
Flutikazono propionatas	50 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
7074	3487	1003487	slėginė talpyklė	120 dozių N1		Receptinis	LT/1/01/1576/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2023-05-31	Išregistruotas
2009-05-13	Perregistruotas
2001-05-16	Registruotas